BCM
AUPH icon

Bluefin Capital Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

Bluefin Capital Management’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-46,700
Closed -$234 – 251
2022
Q4 		$234 Hold
46,700
– – ﹤0.01% 485
2022
Q3 		$6K Hold
46,700
– – ﹤0.01% 482
2022
Q2 		$47K Hold
46,700
– – 0.01% 402
2022
Q1 		$81K Hold
46,700
– – 0.01% 422
2021
Q4 		$381K Sell
46,700
-300
-0.6% -$7.11K 0.03% 397
2021
Q3 		$432K Sell
47,000
-1,000
-2% -$15.9K 0.04% 306
2021
Q2 		$146K Buy
+48,000
New +$611K 0.01% 423
2020
Q2 		– Sell
-72,000
Closed -$56K – 394
2020
Q1 		$56K Sell
72,000
-646,700
-90% -$11.4M 0.01% 319
2019
Q4 		$4.9M Buy
+718,700
New +$6.62M 0.33% 79

Other funds holding AUPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return